ESLAW logo

Estrella Immunopharma (ESLAW) Cash From Operations

Annual CFO

-$16.07 M
-$14.73 M-1102.61%

June 30, 2024

Summary

Performance

1-Year Change

-1102.61%

3-Year Change

-2295.32%

5-Year Change

-2295.32%

15-Year Change

-2295.32%

ESLAW Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$670.82 K

3-Year Low

-$16.07 M
ESLAW annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
ESLAW previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
ESLAW next annual earnings announcement has not yet been scheduled

OtherESLAWcash flowmetrics:

Annual CFI

$4.96 M
ESLAW annual cash flow from investing activities is $4.96 million

Annual CFF

$12.79 M
ESLAW annual cash flow from financing activities is $12.79 million

Annual FCF

-$16.07 M
ESLAW annual free cash flow is -$16.07 million

Annual CAPEX

-
ESLAW annual capital expenditures value is unknown

Quarterly CFO

-$2.22 M
-$1.93 M-660.67%

September 30, 2024

Summary

Performance

3-Month Change

-660.67%

1-Year Change

+80.32%

3-Year Change

+80.32%

5-Year Change

+80.32%

ESLAW Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$108.20 K

3-Year Low

-$11.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ESLAW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ESLAW next earnings announcement has not yet been scheduled

OtherESLAWcash flowmetrics:

Quarterly CFI

$0.00
ESLAW quarterly cash flow from investing activities is $0.00

Quarterly CFF

-$150.47 K
ESLAW quarterly cash flow from financing activities is -$150.47 thousand

Quarterly FCF

-$2.22 M
ESLAW quarterly free cash flow is -$2.22 million

Quarterly CAPEX

-
ESLAW quarterly capital expenditures value is unknown

TTM CFO

-$18.01 M
-$1.94 M-12.09%

September 30, 2024

Summary

Performance

3-Month Change

-12.09%

1-Year Change

-56.04%

3-Year Change

-56.04%

5-Year Change

-56.04%

ESLAW TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$108.20 K

3-Year Low

-$18.01 M
ESLAW TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ESLAW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
ESLAW next earnings announcement has not yet been scheduled

OtherESLAWcash flowmetrics:

TTM CFI

$5.07 M
ESLAW TTM cash flow from investing activities is $5.07 million

TTM CFF

-$7.40 M
ESLAW TTM cash flow from financing activities is -$7.40 million

TTM FCF

-$18.01 M
ESLAW TTM free cash flow is -$18.01 million

TTM CAPEX

-
ESLAW TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ESLAW Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1102.6%+80.3%-56.0%
3 y3 years-2295.3%+80.3%-56.0%
5 y5 years-2295.3%+80.3%-56.0%

ESLAW Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+2295.3%at low+1949.5%+408.1%>+9999.0%at low
5 y5-year+2295.3%at low+1949.5%+408.1%>+9999.0%at low
alltimeall time+2295.3%at low+1949.5%+408.1%>+9999.0%at low

Estrella Immunopharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.22 M(+660.7%)
-$18.01 M(+12.1%)
Jun 2024
-$16.07 M
-$291.51 K(-93.1%)
-$16.07 M(+1.8%)
Mar 2024
-
-$4.23 M(-62.4%)
-$15.78 M(+36.7%)
Dec 2023
-
-$11.27 M(+3994.2%)
-$11.54 M(+2910.6%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$275.19 K(+154.3%)
-$383.39 K(+254.3%)
Jun 2023
-$1.34 M(-7.3%)
-
-
Dec 2022
-
-$108.20 K
-$108.20 K
Jun 2022
-$1.44 M(+115.0%)
-
-
Jun 2021
-$670.82 K
-
-

FAQ

  • What is Estrella Immunopharma annual cash flow from operations?
  • What is the all time high annual CFO for Estrella Immunopharma?
  • What is Estrella Immunopharma annual CFO year-on-year change?
  • What is Estrella Immunopharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Estrella Immunopharma?
  • What is Estrella Immunopharma quarterly CFO year-on-year change?
  • What is Estrella Immunopharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Estrella Immunopharma?
  • What is Estrella Immunopharma TTM CFO year-on-year change?

What is Estrella Immunopharma annual cash flow from operations?

The current annual CFO of ESLAW is -$16.07 M

What is the all time high annual CFO for Estrella Immunopharma?

Estrella Immunopharma all-time high annual cash flow from operations is -$670.82 K

What is Estrella Immunopharma annual CFO year-on-year change?

Over the past year, ESLAW annual cash flow from operations has changed by -$14.73 M (-1102.61%)

What is Estrella Immunopharma quarterly cash flow from operations?

The current quarterly CFO of ESLAW is -$2.22 M

What is the all time high quarterly CFO for Estrella Immunopharma?

Estrella Immunopharma all-time high quarterly cash flow from operations is -$108.20 K

What is Estrella Immunopharma quarterly CFO year-on-year change?

Over the past year, ESLAW quarterly cash flow from operations has changed by +$9.05 M (+80.32%)

What is Estrella Immunopharma TTM cash flow from operations?

The current TTM CFO of ESLAW is -$18.01 M

What is the all time high TTM CFO for Estrella Immunopharma?

Estrella Immunopharma all-time high TTM cash flow from operations is -$108.20 K

What is Estrella Immunopharma TTM CFO year-on-year change?

Over the past year, ESLAW TTM cash flow from operations has changed by -$6.47 M (-56.04%)